Törnqvist Björn, Zheng Zongli, Ye Weimin, Waage Anne, Nilsson Magnus
Department of Surgical Gastroenterology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
Clin Gastroenterol Hepatol. 2009 Sep;7(9):1013-8; quiz 915. doi: 10.1016/j.cgh.2009.05.014. Epub 2009 May 22.
BACKGROUND & AIMS: The aim of this study was to study survival, factors influencing survival, and causes of death after iatrogenic reconstructed bile duct injury in a large population-based Swedish cohort.
Patients who underwent cholecystectomy in the period from 1965 to 2005 were identified from the Swedish Inpatient Register. The bile duct injury cohort consisted of patients with procedure codes indicating reconstructive biliary surgery within 1 year of the cholecystectomy, excluding patients with reconstruction owing to other causes than bile duct injury.
Of 374,042 cholecystectomy patients, 1386 were classified as afflicted by bile duct injury requiring reconstructive surgery. Survival was significantly lower in the injured cohort compared with the noninjured cohort, with a hazard ratio of 3.73 (95% confidence interval, 3.30-4.22) at 1 year that gradually evened out thereafter. The risk of dying from liver diseases was increased 4-fold in the bile duct injury cohort compared with the general population. Older age and comorbidity increased the risk of dying, whereas the use of intraoperative cholangiogram improved survival.
Patients with iatrogenic reconstructed bile duct injury have a decreased survival rate compared with noninjured cholecystectomy patients. Patients' younger age, absence of other diseases, and routine use of intraoperative cholangiogram seem to be positive prognostic survival factors. These patients also may be at increased risk of dying from liver diseases, although this issue requires further study.
本研究旨在对瑞典一个基于人群的大型队列中,医源性重建胆管损伤后的生存率、影响生存的因素及死亡原因进行研究。
从瑞典住院患者登记处识别出1965年至2005年期间接受胆囊切除术的患者。胆管损伤队列由胆囊切除术后1年内有表明重建性胆管手术的程序代码的患者组成,不包括因胆管损伤以外的其他原因进行重建的患者。
在374,042例胆囊切除术患者中,1386例被归类为患有需要重建手术的胆管损伤。与未受伤队列相比,受伤队列的生存率显著较低,1年时的风险比为3.73(95%置信区间,3.30 - 4.22),此后逐渐趋于平稳。与普通人群相比,胆管损伤队列死于肝脏疾病的风险增加了4倍。年龄较大和合并症会增加死亡风险,而术中胆管造影的使用可提高生存率。
与未受伤的胆囊切除术患者相比,医源性重建胆管损伤患者的生存率降低。患者年龄较轻、无其他疾病以及术中胆管造影的常规使用似乎是积极的生存预后因素。这些患者死于肝脏疾病的风险也可能增加,尽管这个问题需要进一步研究。